{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:08:45Z","timestamp":1788876525041,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.reumae.2026.502216","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:22Z","timestamp":1785456022000},"page":"502216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antisynthetase syndrome in Chile: Experience from a clinical cohort"],"prefix":"10.1016","volume":"22","author":[{"given":"Sebasti\u00e1n","family":"Campos Benavente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Prieto-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Neira Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Wolff Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2026.502216_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.959653","article-title":"A multidisciplinary approach to the diagnosis of antisynthetase syndrome","volume":"9","author":"Wells","year":"2022","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.reumae.2026.502216_bib0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.reumae.2026.502216_bib0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.reumae.2026.502216_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866087","article-title":"Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond","volume":"13","author":"Galindo-Feria","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.reumae.2026.502216_bib0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","article-title":"Autoantibodies in polymyositis","volume":"18","author":"Targoff","year":"1992","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.reumae.2026.502216_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome: much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2026.502216_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","article-title":"Myositis autoantibody inhibits histidyl\u2010tRNA synthetase: a model for autoimmunity","volume":"304","author":"Mathews","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.reumae.2026.502216_bib0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12890-021-01399-5","article-title":"Clinical features of antisynthetase syndrome-associated ILD: a Chinese retrospective cohort","volume":"21","author":"Zhan","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.reumae.2026.502216_bib0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/kead671","article-title":"Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centred retrospective cohort study","volume":"64","author":"Tang","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.reumae.2026.502216_bib0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: a distinct disease spectrum","volume":"5","author":"Huang","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"10.1016\/j.reumae.2026.502216_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.reumae.2026.502216_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.resinv.2019.12.003","article-title":"Clinical, radiological, and pathological features of anti-asparaginyl tRNA synthetase antibody-related interstitial lung disease","volume":"58","author":"Aiko","year":"2020","journal-title":"Respir Investig"},{"issue":"2","key":"10.1016\/j.reumae.2026.502216_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.reumae.2026.502216_bib0070","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.reumae.2026.502216_bib0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/art.43038","article-title":"CLASS Project investigators. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project","volume":"77","author":"Faghihi-Kashani","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2026.502216_bib0080","author":"Aggarwal"},{"issue":"9","key":"10.1016\/j.reumae.2026.502216_bib0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.reumae.2026.502216_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4067\/s0034-98872020000200160","article-title":"Manifestaciones cl\u00ednicas y anticuerpos en pacientes chilenos con dermatomiositis","volume":"148","author":"Marav\u00ed","year":"2020","journal-title":"Rev Med Chile"},{"issue":"11","key":"10.1016\/j.reumae.2026.502216_bib0095","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibody specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Cavagna","year":"2019","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"10.1016\/j.reumae.2026.502216_bib0100","first-page":"1789","article-title":"Antisynthetase syndrome: clinical value of Solomon\u2019s and Connors\u2019 diagnosis criteria [abstract]","volume":"78","author":"Greco","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.reumae.2026.502216_bib0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin Pulm Med"},{"issue":"9","key":"10.1016\/j.reumae.2026.502216_bib0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10067-015-3023-x","article-title":"Prognostic factors in a cohort of antisynthetase syndrome: serologic profile is associated with mortality in patients with interstitial lung disease","volume":"34","author":"Rojas-Serrano","year":"2015","journal-title":"Clin Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326001115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326001115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:23:32Z","timestamp":1788873812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574326001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2173574326001115"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502216","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antisynthetase syndrome in Chile: Experience from a clinical cohort","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2026.502216","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502216"}}